- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06427967
A Novel Social Emotional Learning Curriculum for Youth With Epilepsy
Beyond Watching and Waiting: A Pilot Study of a Novel Social Emotional Learning Curriculum-Based Intervention Designed for Youth With Epilepsy at Increased Risk of Future Mental Illness
Youth with epilepsy (YWE) are significantly more likely than their peers without epilepsy to experience isolation, interpersonal victimization, and low relationship satisfaction. This is a serious health concern. Poor social support, real or perceived, is consistently correlated to worsened outcomes in every domain of health-related quality of life. As YWE are two to five times more likely than their peers without epilepsy to develop a mental health condition, poor social support is likely a bidirectional risk factor.
Currently, there are no best practices or recommendations for clinicians or other youth-serving professionals to reference when it comes to improving the perceived social support of YWE specifically.
The research team has drawn from multiple fields of scientific knowledge to develop a novel intervention that aims to provide YWE with knowledge, skills, connections, and positive emotional support that can help them to bolster their support system at every level of the social ecological model (SEM). The proposed study is a pilot of this intervention to test its acceptability and appropriateness according to YWE participants ages 12 to 26. The intervention's impact on participants social-emotional learning skills and the feasibility of expanding the study protocol for use in a large, multisite randomized control trial will also be explored.
The goal of this research study is to help evaluate a new program for young people diagnosed with epilepsy that will build up young people's social opportunities, interpersonal skills, and sources of emotional support. The investigators want to research the impact of this program. From this study, the investigators hope to learn what the program does well, and in what ways it could be improved from the perspective of YWE.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston Medical Center, Neurology and remote
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Able to read, write, and communicate in English at 3rd grade level
- Active epilepsy diagnosis (currently on anti-seizure medication or does not yet meet remission standards of 10 years without seizure and off all medication)
- Epilepsy diagnosis clinically established for at least 6 months prior to the time of recruitment
- The pediatric neurologist feels the patient would benefit from program participation.
- Able to consistently join meetings on Zoom with functional audio and video reception
Exclusion Criteria:
- During the consent process, if an eligible potential participant feels that participation would pose too much of a burden on their health or mental wellbeing, they will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Novel Social-Emotional Learning (SEL) curriculum
Participants assigned to this arm will receive Project Dream Team, the new 5 session SEL curriculum for YWE.
|
Five total sessions, 60-minutes each, with one session every 7 days (+/- 21 days between sessions), Session activities include discussion prompts, interactive learning methods, skill rehearsals, mindfulness / somatic exercises and lecture slides facilitated by a trained facilitator.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of study processes
Time Frame: 4 months
|
Number of sessions attended per participant.
|
4 months
|
|
Acceptability of the intervention
Time Frame: 4 months
|
A likert scale will be used to assess satisfaction from 1 to 10 where 10 is highly acceptable and 1 is not acceptable.
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in perceived social support (PSS)
Time Frame: Baseline, 4 months
|
This outcome will be assessed with the Youth Thrive (YT) Framework Survey Part 1: Social Connections and Concrete Supports combine subscales.
Each YT subscale includes 10 to 16 individual Likert scale questions.
Scores are generated by assigning values of 1 to 5 to the Likert scale (1 = not at all like me, 5 = very much like me) for 'positive items' and an inverse value scale for 'negative items' and then totalling all the items within the subscale.
Higher total scores indicate a higher level of PSS.
|
Baseline, 4 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in social emotional skills and behaviors
Time Frame: Baseline, 4 months
|
The Youth Thrive (YT) Framework Survey Part 2: Youth Resilience, Cognitive and Social-Emotional Competence subscales will be used to assess this outcome.
Each YT subscale includes 10 to 16 individual Likert scale questions.
Scores are generated by assigning values of 1 to 5 to the Likert scale (1 = not at all like me, 5 = very much like me) for 'positive items' and an inverse value scale for 'negative items' and then totalling all the items within the subscale.
Higher total scores indicate a greater depth of knowledge, higher mastery over key skills and more frequent use of prosocial behaviors.
|
Baseline, 4 months
|
|
Change in leveraging social support for epilepsy self management
Time Frame: Baseline, 4 months
|
This outcome will be assessed using the 25 subscale items from the Adult Epilepsy Self-Management Measurement Instrument (AESMMI-65).
The responses are Likert scale-rated from 0 to 5 for positively phrased items, and inversely scored for negatively phrased items.
Each subscale will be scored individually and also totaled for a single composite score.
Higher scores indicate higher use of effective epilepsy self-management strategies.
|
Baseline, 4 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Laurie Douglass, MD, Boston Medical Center, Department of Neurology
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-43875
- 4301210001 (Other Grant/Funding Number: Charles F. Hood Foundation)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustNot yet recruitingEpilepsy Intractable | Epilepsy in Children
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
University Hospital, LilleCompletedFocal Epilepsy | Epilepsy IntractableFrance
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsRecruitingEpilepsy, Drug ResistantChina
Clinical Trials on Project Dream Team
-
Boston University Charles River CampusWayne State UniversityCompletedCerebral Palsy | Intellectual Disability | Developmental Disabilities | Autism | Transition-age Youth
-
Rhode Island HospitalBradley HospitalRecruitingInsomnia | Sleep | Postpartum Depression | Sleep Disturbance | Pregnancy Related | Sleep Deprivation | Sleep HygieneUnited States
-
University of BergenOxford Research; Nordland Research Institute; Voksne for Barn; Bodin Upper Secondary... and other collaboratorsCompletedMental Health | Absence | Drop Out | Academic Achievement/Average Grade
-
Massachusetts General HospitalNot yet recruitingDiabetes Mellitus Type 2United States
-
Intalight, IncRecruitingRetina PathologyUnited States
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsActive, not recruitingDiabetes Mellitus, Type 1United States
-
Robert T. Chang, MDCompleted
-
RANDPatient-Centered Outcomes Research Institute; National Institute of Mental... and other collaboratorsCompletedDepression | Social Determinants of Health | Information DisseminationUnited States
-
University of South CarolinaCenters for Disease Control and PreventionRecruitingArthritis | Osteoarthritis | Lupus Erythematosus, Systemic | Gout | Rheumatoid Arthritis (RA) | Fibromyalgia (FM)United States
-
NYU Langone HealthCompleted